by Site Dev | Oct 26, 2021 | Clinical Trials, Multiple Myeloma
Multiple Myeloma Clinical Trials Contact Us 1)Relapsed/Refractory MM/ IONA: A prospective, non-interventional, multinational, observational study with Isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM) Send UsA Message LOCATION*...
